Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation and Refinement of Noninvasive Diagnostic Biomarkers for Endometriosis, The ENDOmarker Protocol

NCT03161704 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03161704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03161704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation and Refinement of Noninvasive Diagnostic Biomarkers for Endometriosis, The ENDOmarker Protocol
Lead sponsor
Yale University
Phase
Observational
Overall status
Completed
Start date
July 8, 2016
Completion date
December 31, 2019
Enrollment
114 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis